Amgad, Mohamed http://orcid.org/0000-0001-7599-6162
Hodge, James M. http://orcid.org/0000-0002-6253-7394
Elsebaie, Maha A. T.
Bodelon, Clara http://orcid.org/0000-0002-6578-2678
Puvanesarajah, Samantha
Gutman, David A.
Siziopikou, Kalliopi P.
Goldstein, Jeffery A. http://orcid.org/0000-0002-4086-057X
Gaudet, Mia M.
Teras, Lauren R.
Cooper, Lee A. D. http://orcid.org/0000-0002-3504-4965
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA220401, U24CA19436201)
Article History
Received: 17 May 2023
Accepted: 13 October 2023
First Online: 27 November 2023
Competing interests
: L.A.D.C. has invention disclosures registered at the Northwestern Office of Innovation and New Ventures, consults for Tempus, and advises Veracyte and Targeted Bioscience. D.A.G. holds stock options in Histowiz LLC and is a cofounder and stockholder of Switchboard, MD. The other authors declare no competing interests.